Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Gynecol Oncol. 2012 Jan 16;125(2):421–426. doi: 10.1016/j.ygyno.2012.01.008

Table 2.

Association of ERCC1 Expression with Clinical Characteristics

Positive No. Negative No. P value
Age (years) 0.750
 Median (range) 58 (24–84) 58 (30–87)
Race
 White 98 274 0.928
 Black 6 14
 Other* 4 12
Performance Status
 0 49 134 0.970
 1 52 148
 2 7 18
Stage/Debulking 0.936
 Stage III – microscopic 31 90
 Stage III – optimal 53 139
 Stage III – suboptimal 13 42
 Stage IV 11 29
Histology
 Serous 80 241 0.277
 Endometrioid 6 20
 Clear cell 7 10
 Mucinous 0 2
 Others 15 27
Tumor Grade
 1 11 25 0.671
 2 43 111
 3 54 164
*

Other includes Hispanic, Asian or Pacific Islander.

Other histologic subtypes included: mixed epithelial, undifferentiated, transitional cell and adenocarcinoma, not otherwise specified